Armstrong K - Search Results

1

Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients.

Mao JJ, Bowman MA, Stricker CT, DeMichele A, Jacobs L, Chan D, Armstrong K. Mao JJ, et al. Among authors: armstrong k. J Clin Oncol. 2009 Feb 20;27(6):933-8. doi: 10.1200/JCO.2008.18.0679. Epub 2009 Jan 12. J Clin Oncol. 2009. PMID: 19139437

2

Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy.

Armstrong K, Popik S, Guerra C, Ubel PA. Armstrong K, et al. Med Decis Making. 2000 Jul-Sep;20(3):308-13. doi: 10.1177/0272989X0002000307. Med Decis Making. 2000. PMID: 10929853

3

Factors associated with decisions about clinical BRCA1/2 testing.

Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B. Armstrong K, et al. Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11097234

4

BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.

Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL. Shih HA, et al. Among authors: armstrong ka. J Clin Oncol. 2002 Feb 15;20(4):994-9. doi: 10.1200/JCO.2002.20.4.994. J Clin Oncol. 2002. PMID: 11844822

5

Interest in BRCA1/2 testing in a primary care population.

Armstrong K, Weber B, Ubel PA, Guerra C, Schwartz JS. Armstrong K, et al. Prev Med. 2002 Jun;34(6):590-5. doi: 10.1006/pmed.2002.1022. Prev Med. 2002. PMID: 12052018

6

What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?

Coyne JC, Kruus L, Racioppo M, Calzone KA, Armstrong K. Coyne JC, et al. Among authors: armstrong k. Am J Med Genet A. 2003 Jan 30;116A(3):222-8. doi: 10.1002/ajmg.a.10844. Am J Med Genet A. 2003. PMID: 12503096

7

Differences in treatment and outcome between African-American and white women with endometrial cancer.

Randall TC, Armstrong K. Randall TC, et al. Among authors: armstrong k. J Clin Oncol. 2003 Nov 15;21(22):4200-6. doi: 10.1200/JCO.2003.01.218. J Clin Oncol. 2003. PMID: 14615448

8

Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.

Armstrong K, Schwartz JS, Randall T, Rubin SC, Weber B. Armstrong K, et al. J Clin Oncol. 2004 Mar 15;22(6):1045-54. doi: 10.1200/JCO.2004.06.090. Epub 2004 Feb 23. J Clin Oncol. 2004. PMID: 14981106

9

The association between race and attitudes about predictive genetic testing.

Peters N, Rose A, Armstrong K. Peters N, et al. Among authors: armstrong k. Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):361-5. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15006909

10

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.

Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Armstrong K, et al. JAMA. 2005 Apr 13;293(14):1729-36. doi: 10.1001/jama.293.14.1729. JAMA. 2005. PMID: 15827311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,003 results

Search Page

Filters